Healthcare Services

Diabetic Kidney Disease Market to Reach $3.75B by 2030 at 6.1% CAGR

April 21, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

By 2030, What Market Size Is The Diabetic Kidney Disease Market Expected To Reach Based On Its 2026 Value?

The diabetic kidney disease market has experienced robust expansion in recent years. It is anticipated to increase from $2.8 billion in 2025 to $2.96 billion in 2026, at a compound annual growth rate (CAGR) of 5.9%. This historical growth can be attributed to several factors, including the high prevalence of diabetes-related kidney damage, late-stage disease diagnosis, limited early screening adoption, reliance on dialysis at advanced stages, and rising hospitalization rates.

The diabetic kidney disease market size is projected to undergo substantial expansion in the coming years. It is anticipated to reach $3.76 billion by 2030, driven by a compound annual growth rate (CAGR) of 6.1%. This growth during the forecast period can be primarily attributed to advancements in renal protective drugs, the increasing number of early diagnosis initiatives, the escalating burden of chronic kidney disease, the broadening reach of specialty nephrology care, and a heightened focus on personalized treatment strategies. Furthermore, major trends expected during this period include the rising adoption of early renal screening, expanded use of renoprotective drug therapies, the growth of combination treatment approaches, an increased emphasis on delaying disease progression, and the integration of multidisciplinary care models.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/diabetic-kidney-disease-global-market-report

Which Key Factors Are Driving The Diabetic Kidney Disease Market Growth?

The escalating incidence of chronic kidney disease (CKD) is anticipated to drive expansion within the diabetic kidney disease market. CKD is characterized as a progressive, long-term illness leading to a gradual decline in kidney function, which can result in various complications such as high blood pressure, anemia, and bone diseases. The necessary diagnostic and treatment interventions for CKD are consequently boosting the diabetic kidney disease market. For instance, according to Kidney Research UK, a prominent UK charity, in June 2023, chronic kidney disease was reported to affect around 7.2 million people in the United Kingdom, comprising over 10% of the population. Among these, 3.25 million individuals were in the most severe stages of the disease, whereas approximately 3.9 million were in the early stages, often remaining untreated and asymptomatic. Projections further suggest that the overall number of people with chronic renal disease in the United Kingdom could escalate to 7.61 million by 2033. Consequently, the growing prevalence of chronic kidney disease is a significant driver for the future growth of the diabetic kidney disease market.

What Are The Main Segments Within The Diabetic Kidney Disease Market Segment Structure?

The diabetic kidney disease market covered in this report is segmented –

1) By Type: Type 1 Diabetes, Type 2 Diabetes

2) By Treatment: Angiotensin Receptor Blockers (Arbs), Angiotensin-Converting Enzyme (Ace) Inhibitors, Antioxidant Inflammation Modulator, Calcium Channel Blockers, Other Treatments

3) By End User: Hospitals, Homecare, Specialty Centers, Other End Users

Subsegments:

1) By Type 1 Diabetes: Autoimmune-Related Diabetic Kidney Disease, Early-Onset Diabetic Kidney Disease

2) By Type 2 Diabetes: Obesity-Related Diabetic Kidney Disease, Late-Onset Diabetic Kidney Disease

Which Trends Are Guiding The Direction Of The Diabetic Kidney Disease Market?

Major companies in the diabetic kidney disease market are focused on integrating advanced solutions like artificial intelligence (AI)-enabled prognostic platforms to improve early risk stratification, personalized disease management, and long-term patient outcomes. These AI-enabled prognostic platforms are diagnostic tools that combine blood-based biomarker measurements with machine-learning algorithms to predict the likelihood of progressive kidney decline, enabling features such as risk-score generation, patient stratification, and early clinical intervention planning. For instance, in June 2023, Renalytix plc, a UK-based diagnostics company, received U.S. Food and Drug Administration (FDA) De Novo marketing authorization for KidneyIntelX.dkd, an AI-driven prognostic platform engineered to assess the risk of significant kidney function decline in adults with type 2 diabetes and early-stage chronic kidney disease. The platform includes biomarker-integrated machine-learning algorithms, cloud-based workflow integration, and stratified risk reporting. KidneyIntelX.dkd enhances clinical decision-making, supports targeted monitoring strategies, and improves proactive care planning.

Who Are The Companies Participating In The Diabetic Kidney Disease Market?

Major companies operating in the diabetic kidney disease market are AstraZeneca plc, Pfizer Inc., Novartis AG, Bayer AG, Sanofi SA, Teva Pharmaceutical Industries Ltd., Bristol-Myers Squibb Company, Sun Pharmaceutical Industries Ltd., Aurobindo Pharma Ltd., Fresenius SE & Co. KGaA, F. Hoffmann-La Roche AG, Abbott Laboratories, Reata Pharmaceuticals Inc., Merck & Co., Mitsubishi Tanabe Pharma Corporation, Johnson & Johnson pvt. Ltd., Eli Lilly and Company, GlaxoSmithKline plc, AbbVie Inc., Boehringer Ingelheim International GmbH, Chugai Pharmaceutical Co. Ltd., Daiichi Sankyo Company Limited

Get The Full Diabetic Kidney Disease Market Report:

https://www.thebusinessresearchcompany.com/report/diabetic-kidney-disease-global-market-report

Which Region Leads The Diabetic Kidney Disease Market In Overall Market Size?

North America was the largest region in the diabetic kidney disease market in 2025. The regions covered in the diabetic kidney disease market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Diabetic Kidney Disease Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/diabetic-kidney-disease-global-market-report

Browse Through More Reports Similar to the Global Diabetic Kidney Disease Market 2026, By The Business Research Company

Rare Kidney Diseases Market Report 2026

https://www.thebusinessresearchcompany.com/report/rare-kidney-diseases-global-market-report

Kidney Disease Market Report 2026

https://www.thebusinessresearchcompany.com/report/kidney-disease-global-market-report

Chronic Kidney Disease Market Report 2026

https://www.thebusinessresearchcompany.com/report/chronic-kidney-disease-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795